In addition to being one of the nine vaccine candidates which have reached the critical last leg of clinical trials, the Oxford vaccine was also found to provide “double immunity” against the COVID-19 in the safety results of its Phase I trials. While the Oxford vaccine did trigger the production of both the protective antibodies and “Killer T-cells” in the body, it should be noted that the incidence of mild side-effects were quite high.
According to a report published in the Lancet, 70 per cent of the volunteers who were dosed with the Oxford vaccine candidate experienced fatigue, mild fever, chills, headache and muscle ache. The reachers had maintained that all the side-effects were manageable and most of them resolved on their own.
This article has been aggregated from timesofindia.indiatimes.com and they maybe/are the copyright owners of the same. If you are the Author/Copyright owner of this article and want us to remove the same then send an email to email@example.com so that we can delete it immediately. We sincerely regret and apologies for any inconvenience caused to you due to the same. Though it is your decision but please take note that the link to your website and the article have been given above, within and on the bottom of the article.